| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/29/2008 | WO2007103468A3 Use of vx-702 for treating rheumatoid arthritis |
| 05/29/2008 | US20080125492 Medicaments Containing Panthenol |
| 05/29/2008 | US20080125478 Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety |
| 05/29/2008 | US20080125477 7-(acryloyl) indole compositions and methods of making and using same |
| 05/29/2008 | US20080125469 Thiadiazole compounds and methods of use thereof |
| 05/29/2008 | US20080125435 E. g., 1-(3-chloro-phenyl)-3-[1-(7-chloro-quinolin-4-yl)-piperidin-4-yl]-thiourea; regulation of ovulation, modulation of prostaglandin E2 receptors; fertilization, nidation, decidualization (e.g. placenta formation) and menstruation; hypermenorrhea, dysmenorrhea; endometriosis; anticarcinogenic agents |
| 05/29/2008 | US20080125426 7-(4-Chlorophenyl)-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; reversible inhibitors of cysteine proteases S, K, F, L, B; diseases associated with Cathepsin S; antiinflammatory agent, autoimmune diseases; asthma, rheumatoid arthritis, multiple sclerosis, Alzheimer's and Crohn's disease |
| 05/29/2008 | US20080125418 Benzimidazole derivatives and their use as kdr kinase protein inhibitors |
| 05/29/2008 | US20080125415 Novel methods for treatment of diseases related to activated lymphocytes |
| 05/29/2008 | US20080125399 N-[3-(trifluoromethyl)pyridin-2-yl]-4-methyl-6-methyl-3-oxo-4-aza-5 alpha -androst-5-en-17 beta -acetamide; useful for the treatment of conditions caused by androgen deficiency such as osteoporosis, osteopenia, glucocorticoid-induced osteoporosis, periodontal disease, cancer cachexia, Alzheimer's disease |
| 05/29/2008 | US20080124743 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (u1) |
| 05/29/2008 | US20080124413 Novel composition containing extracts of butyrospermum parkii and the use of such a composition for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation hypersensitivity or pain |
| 05/29/2008 | US20080124402 N-(Pyridin-3-Yl)-2-Phenylbutanamides As Androgen Receptor Modulators |
| 05/29/2008 | US20080124374 Decellularized bone marrow extracellular matrix |
| 05/29/2008 | US20080124358 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 05/29/2008 | US20080124342 Anti-Tnf Alpha Antibodies Which Selectively Inhibit Tnf Alpha Signalling Through The P55R |
| 05/29/2008 | US20080124317 Diagnos and Treatment of Fibrosis Related Pathology |
| 05/29/2008 | CA2670340A1 Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators |
| 05/29/2008 | CA2669124A1 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity |
| 05/29/2008 | CA2669104A1 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity |
| 05/29/2008 | CA2669102A1 Tetralin analogs having sphingosine 1-phosphate agonist activity |
| 05/29/2008 | CA2664734A1 Method of drug delivery for bone anabolic protein |
| 05/28/2008 | EP1925301A1 Use of tricyclic diterpenes and their derivatives for the treatment, co-treatment or prevention of inflammatory disorders and/or joint disorders |
| 05/28/2008 | EP1924579A2 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 05/28/2008 | EP1711177B1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS |
| 05/28/2008 | EP1660475B1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/28/2008 | EP1496898B1 Tyrosine kinase inhibitors |
| 05/28/2008 | EP1494992B1 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 05/28/2008 | EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 05/28/2008 | EP1424326B1 Fused-polycyclic compounds |
| 05/28/2008 | EP1399155B1 Small molecules useful in the treatment of inflammatory disease |
| 05/28/2008 | EP1326630B1 Use of glp-2 peptides |
| 05/28/2008 | EP1066315B1 Use of inhibitors of mammalian asparaginyl endopeptidase for modulating the immune system |
| 05/28/2008 | CN101188949A Egg-derived bone-strengthening composition |
| 05/28/2008 | CN101186626A Glucosamine and method of making glucosamine from microbial biomass |
| 05/28/2008 | CN101185750A Medicine bag for treating hyperosteogeny |
| 05/28/2008 | CN101185745A Hyperosteogeny ache eliminating liquid |
| 05/28/2008 | CN101185743A Ointment shape medicament for treating soft tissue contusion |
| 05/28/2008 | CN101185730A Ache relieving mixture for treating urarthritis |
| 05/28/2008 | CN101185718A Medicine for treating bone joint disease and its preparation method |
| 05/28/2008 | CN101185713A Medicine preparation for treating traumatic injuries and its preparation method and quality control method |
| 05/28/2008 | CN101185712A Orally-administered traditional Chinese medicine for treating knee joint hyperosteogeny |
| 05/28/2008 | CN101185699A Traditional Chinese medicine decoction for treating cervical spondylosis |
| 05/28/2008 | CN101185681A Medicinal composition for treating rheumatoid arthritis and preparation method and application |
| 05/28/2008 | CN101185672A Orally-administered traditional Chinese medicine decoction for treating lumbar hyperosteogeny |
| 05/28/2008 | CN101185670A Tincture medicine for treating ganglion |
| 05/28/2008 | CN101185663A Method for obtaining the extraction from caper medicinal part and application of the extraction |
| 05/28/2008 | CN101185659A Intermediate compound of a traditional Chinese medicinal preparation and preparation method and application thereof |
| 05/28/2008 | CN101185643A Application of (E)-1-(2, 4-dihydroxy-5-(3-methyl-butyl-2-alkenyl) phenyl)-3-(4-hydroxy-phenyl) propylene-2-ketone-1 in medicine |
| 05/28/2008 | CN101185621A Chinese medicinal herb antimicrobial hand cleanser and preparation method thereof |
| 05/28/2008 | CN100390179C Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 05/28/2008 | CN100390163C 2-(2,6-dioxopiperidin-3-yl)-isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 05/28/2008 | CN100390158C Novel theterocyclic analogs of diphenylethylene compounds |
| 05/28/2008 | CN100390154C Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors |
| 05/28/2008 | CN100389826C Remedies for arthritis |
| 05/28/2008 | CN100389821C Stabilized liquid polypeptide-containing pharmaceutical composition |
| 05/28/2008 | CN100389800C Medicinal preparation for treating cold abscess and all kinds of body surface ulcer |
| 05/28/2008 | CN100389789C Preparation method of capsule containing red sage root and notoginseng |
| 05/28/2008 | CN100389786C Wind arthralgia treating wine and manufacturing method thereof |
| 05/28/2008 | CN100389777C Moderate molecular weighted chondroitin sulfate injection and its preparing process |
| 05/28/2008 | CN100389772C Use of zolendronate for mfg. medicament for treatment of bone metabolism diseases |
| 05/28/2008 | CN100389765C Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids |
| 05/28/2008 | CN100389749C Manufacturing method of medicine for treating osteosis |
| 05/27/2008 | US7378444 Antiinflammatory agents; cardiovascular disorders; vision disorders; skin disorders; central nervous system disorders; antiarthritic agents |
| 05/27/2008 | US7378413 2-amino-3-(alkyl)-pyrimidone derivatives |
| 05/27/2008 | US7378404 For therapy of estrogen-deficiency-induced diseases and conditions |
| 05/27/2008 | US7378403 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding |
| 05/27/2008 | CA2423357C Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| 05/22/2008 | WO2008061029A1 Aryl sulfonamide derivatives and methods of their use |
| 05/22/2008 | WO2008061016A1 N-substituted piperidinyl 4 -arylsulfonamides as modulators of the secreted frizzled related protein- 1 |
| 05/22/2008 | WO2008061006A1 Substituted indan-2-yl, tetrahydronaphthalen-2-yl, or dihydr0-2h-chr0men-3-yl arylsulfonamides and methods of their use |
| 05/22/2008 | WO2008060999A1 Piperidinyl arylsulfone derivatives as modulators of secreted frizzled related protein-1 |
| 05/22/2008 | WO2008060998A1 Indole sulfonamides as sfrp-1 modulators |
| 05/22/2008 | WO2008060609A1 Crystalline forms of ibandronate sodium |
| 05/22/2008 | WO2008059927A1 Collagen peptide composition and food or beverage containing the same |
| 05/22/2008 | WO2008059869A1 Method of degrading polysaccharide |
| 05/22/2008 | WO2008059819A1 Seaweed-derived immunostimulant and antiinflammatory agent |
| 05/22/2008 | WO2008059197A2 Topical composition comprising an anti- inflammatory steroid and a non-steroidal anti -inflammatory drug |
| 05/22/2008 | WO2008058679A2 Novel amides acting on the adenosine receptors |
| 05/22/2008 | WO2008058514A1 Preparations comprising boswellic acids for inhibiting the synthesis of prostaglandin e2 |
| 05/22/2008 | WO2008058333A1 Topical formulation and uses thereof |
| 05/22/2008 | WO2008042968A3 Di-fluoro containing compounds as cysteine protease inhibitors |
| 05/22/2008 | WO2007120702A3 Use of gpr119 receptor agonists for increasing bone mass and for treating osteoporosis, and combination therapy relating thereto |
| 05/22/2008 | US20080119859 Multi-Purpose Bio-Material Composition |
| 05/22/2008 | US20080119555 Aryl Alkyl Sulfonamides As Therapeutic Agents For The Treatment Of Bone Conditions |
| 05/22/2008 | US20080119526 Ep2 receptor agonists |
| 05/22/2008 | US20080119515 Heterocyclic Kinase Inhibitors: Methods of Use and Synthesis |
| 05/22/2008 | US20080119514 6-(2,4-dinitrophenylazo)-2,5,7,8-tetramethyltridecyl))-1,2,3,4-tetrahydroquinoline; to treat cell proliferative diseases |
| 05/22/2008 | US20080119513 To treat osteoarthritis; matrix metalloproteinases-13 inhibitors |
| 05/22/2008 | US20080119497 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
| 05/22/2008 | US20080119474 5,6-bis(4-methoxyphenyl)-2-ethyl-2H-pyridazin-3-one; interleukin-1 beta antagonist; collagenase inhibitor; analgesic, antiinflammatory, antiarthritic, antiischemic agents; autoimmune disease, rheumatic diseases; osteoporosis |
| 05/22/2008 | US20080119469 Novel Compounds |
| 05/22/2008 | US20080119468 Phthalazine, aza-and diaza-phthalazine compounds and methods of use |
| 05/22/2008 | US20080119411 use of salmon calcitonin in combination with PTH for the oral administration of PTH for the treatment of osteoporosis without the potentially toxic hypercalcemic side effects |
| 05/22/2008 | US20080119410 comprising administering bactericidal/permeability-increasing protein (BPI proteins) or fragments to a patient suffering from age related macular degeneration (ARMD) |
| 05/22/2008 | US20080119407 Vitamin D Receptor Modulators |
| 05/22/2008 | US20080119406 caltrin or functionally active peptide fragment together with a pharmaceutically acceptable carrier; osteroporosis, osteoarthritis, Paget's disease, osteomalacia, prolonged bed rest, chronic disuse of a limb, anorexia, microgravity, exogenous and endogenous gonadal insufficiency, bone fracture |
| 05/22/2008 | US20080118588 Anti-arthritic herbal composition and method thereof |
| 05/22/2008 | US20080118581 Method for preparing a centella asiatica extract rich in madecassoside and in terminoloside |
| 05/22/2008 | US20080118542 Growth Factor Composition |